GlassScriptPhysician profile
Daniel Delgaizo
NPI 1205057577
$25,413.21
in general payments reported to CMS, 2019-2025
15 companies · $3,070 in 2025
The $3,070 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $2,494 · 2021: $3,641 · 2022: $2,270 · 2023: $1,001 · 2024: $12K · 2025: $3,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $1,422 · Travel and Lodging: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,242.06 |
| Food and Beverage | $1,422.43 |
| Travel and Lodging | $324.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $14,350.14 | 2021-2025 | Attune |
| Zimmer Biomet Holdings, INC. | $3,339.11 | 2020-2024 | Persona |
| Medacta USA, INC. | $2,995.96 | 2020-2021 | |
| Stryker Corporation | $1,781.42 | 2022-2023 | Mako |
| Depuy Synthes Sales INC. | $1,012.89 | 2020-2025 | Velys, Attune |
| Orthalign INC | $750.00 | 2019 | |
| Spr Therapeutics, INC | $337.50 | 2024 | Sprint Pns System |
| Conformis, INC. | $269.86 | 2019 | |
| Smith+Nephew, INC. | $211.58 | 2022-2025 | Real Intelligence, Pico, Journey II |
| Osteoremedies, LLC | $149.50 | 2025 | Biobrush, Osteoboost Select 5cc, Biowash Surgical Irrigation |
| Peerless Surgical INC. | $137.62 | 2025 | |
| Solventum Corporation | $23.88 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Curonix LLC | $20.44 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $18.57 | 2023 | Proclaim |
| Innovation Technologies INC | $14.74 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Delgaizo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.